Plotkin's Vaccines

Pneumococcal Polysaccharide Vaccines

BACKGROUND Since the late 19th century, the study of Streptococcus pneumoniae and pneumococcal infections has occupied a central position in developing a scientific basis for controlling infectious diseases. , The organism was first isolated and grown in the laboratory almost…

Plague Vaccines

E. Diane Williamson, PhD, DSc Defence Science and Technology Laboratory CBR Division Defence Science and Technology Laboratory, Porton Down, Salisbury Wiltshire United Kingdom Petra C.F. Oyston, PhD, BSc(Hons) Defence Science and Technology Laboratory CBR Division Dstl Porton Down, Salisbury Wiltshire…

Pertussis Vaccines

INTRODUCTION History of Disease Pertussis (whooping cough) is a bacterial respiratory infection caused by Bordetella pertussis, a Gram-negative bacillus. Its major manifestation is a protracted cough that lasts many weeks, marked by characteristic intense paroxysms that often terminate in an…

Parasitic Disease Vaccines

Parasitic diseases caused by helminths and unicellular eukaryotes (protozoa) are major causes of human disease in the resource-poor nations of the tropics. The Institute for Health Metrics and Evaluation’s Global Burden of Disease Study for 2019 estimated that 643,000 people…

Norovirus

Human noroviruses (HuNoVs) have become the leading cause of acute nonbacterial gastroenteritis in countries where rotavirus vaccination has been successfully implemented. Overall, HuNoVs have been identified in ~18% of reported acute gastroenteritis cases worldwide. In the United States, HuNoVs result…

Noninfectious Disease Vaccines

This chapter provides an overview of the challenges and advances in vaccine development for chronic and noncommunicable diseases. Because of space limitations it is not possible to provide an exhaustive representation of the field; consequently, we address a few major…

Mumps Vaccines

HISTORY OF THE DISEASE The clinical picture of mumps was first described by Hippocrates in the 5th century bc in his first book of Epidemics , in which he described outbreaks among young males characterized by swelling about one or…

Meningococcal Vaccines Directed at Capsular Group B

## Meningococcal disease was first described in Geneva, Switzerland in 1805. Different capsular groups of meningococci were first recognized serologically in 1909, and serogroup B was defined based on the immunological difference in capsular polysaccharide structure in the 1940s. Capsular…